Genetic tests and drug-discovery tools that help psychiatric researchers and drug companies identify borderline personality disorder risk and choose treatment targets.
Diagnostics & therapeutic discovery for borderline personality disorder
Nature’s 20 July 2026 report of the first genetic clues for borderline personality disorder means researchers and companies can now develop genetic risk panels and prioritize candidate drug targets, creating a clear path to diagnostics and more targeted treatments for a disorder that has long lacked biological markers.
Projected Score
as a side gig ☆☆☆☆☆ (0/5)
no money or audience ☆☆☆☆☆ (0/5)
with both ★★☆☆☆ (2/5)
Want this one researched? Commission the full dossier for $15: we research and write it, and you read it first. Then you choose — pay more to keep it exclusive, or do nothing and it goes public on this site. The score above is our forecast for a dossier we haven’t written yet.
The news behind it
- Jul 20, 2026 Nature: Huge study finds first genetic clues for borderline personality disorder
